Former President Donald Trump has announced a sweeping new set of tariffs targeting several key import sectors, including pharmaceuticals, heavy-duty trucks, and household furniture. The new measures, set to take effect on October 1, are expected to significantly impact trade, consumer prices, and healthcare costs in the U.S.
Trump detailed the tariff plan as follows:
-
100% tariff on imported branded pharmaceutical drugs
-
25% tariff on heavy-duty truck imports
-
50% tariff on kitchen cabinets and bathroom vanities
-
30% tariff on upholstered furniture
The announcement has drawn sharp criticism from drug companies and healthcare advocates who warn that doubling the cost of some imported medicines could have life-threatening consequences. The U.S. imported nearly $233 billion in pharmaceutical products in 2024. Advocacy groups and experts fear this move could lead to rising healthcare costs, shortages, and patients rationing or skipping essential medications.
Trump has indicated that pharmaceutical companies investing in U.S. manufacturing—defined as those currently building or expanding domestic production—could be exempt. Companies such as AstraZeneca, Roche, Novartis, Eli Lilly, and Johnson & Johnson have already announced U.S. investment plans, which Trump’s administration has portrayed as a victory.
The tariffs on heavy-duty trucks are intended to protect domestic manufacturers like Peterbilt, Kenworth, and Freightliner from what Trump called “unfair outside competition.” However, critics argue the move could increase transportation costs, especially as Mexico, the largest exporter of heavy trucks to the U.S., plays a vital role in the supply chain. Many trucks imported from Mexico include about 50% U.S. content, according to Mexican officials.
Additional tariffs on kitchen and bathroom furnishings have been justified by Trump on national security grounds, citing “flooding” of imported products that hurt U.S. manufacturers.
The market reacted negatively to the announcement, with major indexes and global markets declining due to fears of rising inflation, consumer price hikes, and slowing job growth. Economists warn the move may undercut the U.S. economy’s recovery by increasing costs across sectors and adding pressure to an already strained supply chain.
